Table 3: Test Indication.
| Test | Indication | Characteristics |
|---|---|---|
| Chromogranin A | General marker for NETs | Specificity and sensibility limitations |
| 5-HIAA | Carcinoid syndrome, midgut tumour | Specific for carcinoid syndrome. Particular attention to potential false positive results |
| Gastrin | Gastric, pancreas and duodenum NETs | Useful for differentiation of stomach NET, indicated for pancreatic or duodenal gastrinoma |
| Secretin | Complementary to gastrin measurement (when levels are 200–1000 pg/mL) | Difficult to access |
| Insulin, pro-insulin, C Peptide after 72-h fasting | Insulinoma | Indicated when glycemic levels ≤nd mg/dl and concentration of insulin ≥6 µU/l. Hospitalisation required |
| Glucagon | Glucagonoma | After 8-h fasting |